#1 Clinical Trials Search in Europe
EU – Europe
AT – Austria
HR – Croatia
CZ – Czech Republic
DK – Denmark
EE – Estonia
FI – Finland
FR – France
DE – Germany
IS – Iceland
IT – Italy
LV – Latvia
LT – Lithuania
NL – Netherlands
NO – Norway
PL – Poland
PT – Portugal
RO – Romania
SK – Slovakia
SI – Slovenia
ES – Spain
SE – Sweden
  • Find a Clinical Trial

    Search Trials by Disease

    Non-small cell lung cancer Breast cancer Plasma cell myeloma Neoplasm Neoplasm malignant Acute myeloid leukaemia Colitis ulcerative Obesity Colorectal cancer metastatic Prostate cancer Crohn's disease Dementia Alzheimer's type Colorectal cancer Ovarian cancer Hepatocellular carcinoma Breast cancer metastatic Dermatitis atopic Asthma Non-small cell lung cancer metastatic Malignant melanoma More trials…
  • Rare Diseases Treatments

    Search Trials by Disease

    Mantle cell lymphoma stage II Hypophosphatasia Aicardi-Goutieres syndrome Neuronal ceroid lipofuscinosis Rhabdomyosarcoma recurrent Cytomegalovirus infection Thrombocytosis Salivary gland cancer B-cell small lymphocytic lymphoma refractory Epstein-Barr virus infection Hyperchylomicronaemia Hypotransferrinaemia Muscular dystrophy Oesophageal adenocarcinoma stage III Infertility male More trials…

    Learn about Rare Diseases

    Rosai-Dorfman syndrome Gaucher’s disease type III – Trials in Disease Sarcoma Progressive supranuclear palsy – Treatment Small intestine leiomyosarcoma – Trials in Disease Alexander disease – Treatment Haemophilia B without inhibitors – Life with Disease Propionic acidaemia – Life with Disease Sjogren’s syndrome – Life with Disease Haemophilia More diseases
  • Vaccine Clinical Trials
  • Pediatric Clinical Trials
  • Resources for Patients

    Browse Innovative Treatments

    Eye103 Cetuximab Gen1046 Folic Acid, Anhydrous Nicotinamide Redasemtide Deupirfenidone GSKVX000000025896 The-630 Resiniferatoxin Ace Inhibitors, Plain 99MTC-EUK-(SO3)CY5-MAS3 Octreotide Benserazide Hydrochloride Magnesium Sulfate Heptahydrate Cerebrolysin Concentrate DICLOFENAC POTASSIUM Indometacin Sisunatovir Varnimcabtagene Autoleucel More therapies…

    Learn about Your Condition

    Medulloblastoma recurrent Abdominal infection Organ donor Diabetic autonomic neuropathy Ligament operation Ovarian cancer stage III Transitional cell carcinoma Hyperthyroidism Pericarditis Keratosis follicular Urinary tract infection Sarcoma metastatic Diffuse large B-cell lymphoma Tendon injury Round cell liposarcoma More diseases
  • Healthy Volunteers
  • Patient Guide
  • Our Partners
  • About Us
  • Contact us
  • Region
    🇪🇺 Europe
    🇦🇹 Austria
    🇭🇷 Croatia
    🇨🇿 Czech Republic
    🇩🇰 Denmark
    🇪🇪 Estonia
    🇫🇮 Finland
    🇫🇷 France
    🇩🇪 Germany
    🇮🇸 Iceland
    🇮🇹 Italy
    🇱🇻 Latvia
    🇱🇹 Lithuania
    🇳🇱 Netherlands
    🇳🇴 Norway
    🇵🇱 Poland
    🇵🇹 Portugal
    🇷🇴 Romania
    🇸🇰 Slovakia
    🇸🇮 Slovenia
    🇪🇸 Spain
    🇸🇪 Sweden

Blood iron increased

  • Study on the Use of Human Apotransferrin for Treating Patients with Atransferrinemia

    Recruiting

    2 1 1
    Investigated Diseases:
    • Blood iron increased
    • Congenital hypotransferrinaemia
    • Hypochromic anaemia
    Investigated Drugs:
    • Human Apotransferrin
    Germany Italy Spain

Investigational Drugs in This Location

See which drug candidates are part of clinical trials near you. Click for detailed trial information.

Medical Conditions Being Studied in This Location

Explore diseases currently included in clinical trials near you. Click to view trials and details for each condition.

European Clinical Trials Information Network

The European Clinical Trials Information Network is transforming access to clinical trial information for patients across Europe. By overcoming language barriers, our platform allows everyone, regardless of their native language, to easily find relevant and comprehensible clinical trial data. This innovative service connects patients to cutting-edge treatments, creating a unified European community where health and progress transcend borders.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic centres, national regulators, and commercial sponsors. We aim to keep all content accurate and up to date.

Explore the full ecosystem of clinical research in Europe.

The information provided on this website is mainly derived from international public clinical trial databases (CTIS.eu). In addition, we are including supplementary sources, such as information provided by academic centers and national regulators, as well as information supplied by commercial sponsors (pharmaceutical companies and contract research organizations). We try to ensure that the information provided is accurate and up to date.

Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).

The website is published by:
CTIN POLAND sp. z o.o.
with its registered office in Warsaw,
ul. rtm. Witolda Pileckiego 67/109,
02-781 Warsaw, Poland,
entered in the Register of Entrepreneurs of the National Court Register under KRS number 0001111334,
REGON: 528919042, NIP (Tax ID): 9512598637
Contact us

© 2026 CTIN Poland

Privacy Policy

Terms and Conditions

Contact

For Sites and Sponsors

Clinical Trial Locations

We use cookies

The website uses cookies to ensure the proper functioning of the site and to analyze internet traffic. Some cookies are essential for using the service and do not require consent. You can accept all cookies or use only the essential ones. Data is processed in accordance with our Privacy Policy. You have the right to withdraw your consent, access, rectify, delete, or limit the processing of your data at any time.
Numer nieprawidłowy!
Numer nieprawidłowy!